Su1676: CLINICAL, GENETIC, BEHAVIORAL AND SOCIAL DETERMINANTS OF HEALTH FACTORS ASSOCIATED WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND SIGNIFICANT FIBROSIS AMONG ADULTS WITH DIABETES: ANALYSIS OF A PROSPECTIVE COHORT OF 548 INDIVIDUALS
Monica A. Tincopa(University of California San Diego), Rohit Loomba(University of California San Diego), Harris Siddiqi(University of California San Diego), Veeral Ajmera(University of California San Diego), Seema Singh(University of Mississippi Medical Center), Richele Bettencourt(University of California San Diego), Lisa Richards(University of California San Diego), Egbert Madamba(University of California San Diego), Maria Elena Martinez, Denise Kalmaz(University of California San Diego)
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k